Exclusive: RNA firm Eterna Therapeutics buys neighboring startup for $50M


An RNA firm called Eterna Therapeutics Inc. just bought its next-door neighbor for as much as $50 million.

Previous Podcast: Iter Investment's Dustin Robinson on the psychedelic sector's promise and appeal for investors
Next Target Field to host The Killers, Imagine Dragons at new TC Summer Fest